mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.4 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.4 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |